Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. M. Burdennyy
Hypermethylation of the microRNA miR-124, miR-125b, miR-127, and miR-129 in Ovarian Carcinoma Is Involved in Suppression of Their Expression and Associated With Both the Development and Progression of Ovarian Cancer
Almanac of Clinical Medicine
Related publications
Clinical Relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Decreased Expression of miR-125b and miR-100 in Oral Cancer Cells Contributes to Malignancy
Genes Chromosomes and Cancer
Cancer Research
Genetics
Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis
International Journal of Oncology
Cancer Research
Oncology
miR-28-5p Promotes the Development and Progression of Ovarian Cancer Through Inhibition of N4BP1
International Journal of Oncology
Cancer Research
Oncology
Expression of miR-224-5p Is Associated With the Original Cisplatin Resistance of Ovarian Papillary Serous Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
IFN-α Regulates Blimp-1 Expression via miR-23a and miR-125b in Both Monocytes-Derived DC and pDC
PLoS ONE
Multidisciplinary
Overexpression of miR‑221 and miR‑222 in the Cancer Stroma Is Associated With Malignant Potential in Colorectal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
The miR-200 Family Controls -Tubulin III Expression and Is Associated With Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
